These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10408781)

  • 1. Osteogenesis imperfecta: mosaicism and refinement of the genotype-phenotype map in OI type III. Mutations in brief no. 242. Online.
    Lund AM; Aström E; Söderhäll S; Schwartz M; Skovby F
    Hum Mutat; 1999; 13(6):503. PubMed ID: 10408781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
    Lund AM; Skovby F; Schwartz M
    Hum Mutat; 1997; 9(5):431-6. PubMed ID: 9143923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.
    Wang Q; Orrison BM; Marini JC
    J Biol Chem; 1993 Nov; 268(33):25162-7. PubMed ID: 7693712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
    Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
    Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a missense mutation of c.3064G>A, Gly1022Ser in exon 43 of COL1A1 gene in a girl with osteogenesis imperfecta type III.
    Chen CP; Lin SP; Suo YN; Chern SR; Su JW; Wang W
    Genet Couns; 2012; 23(3):359-65. PubMed ID: 23072183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
    Lindahl K; Åström E; Rubin CJ; Grigelioniene G; Malmgren B; Ljunggren Ö; Kindmark A
    Eur J Hum Genet; 2015 Aug; 23(8):1042-50. PubMed ID: 25944380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations.
    Liu Y; Song L; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Song Y; Xing X; Asan ; Li M
    Clin Chim Acta; 2016 Oct; 461():172-80. PubMed ID: 27450065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV.
    Lund AM; Nicholls AC; Schwartz M; Skovby F
    Acta Paediatr; 1997 Jul; 86(7):711-8. PubMed ID: 9240878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
    Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
    J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study.
    Andersson K; Dahllöf G; Lindahl K; Kindmark A; Grigelioniene G; Åström E; Malmgren B
    PLoS One; 2017; 12(5):e0176466. PubMed ID: 28498836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene.
    Cohen-Solal L; Zolezzi F; Pignatti PF; Mottes M
    Mol Cell Probes; 1996 Jun; 10(3):219-25. PubMed ID: 8799376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
    Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
    Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mild variant of osteogenesis imperfecta type I caused by a Gly1088Glu mutation in COL1A1.
    Xia XY; Li WW; Li N; Wu QY; Cui YX; Li XJ
    Mol Med Rep; 2014 Jun; 9(6):2187-90. PubMed ID: 24682174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderately severe osteogenesis imperfecta associated with substitutions of serine for glycine in the alpha 1(I) chain of type I collagen.
    Marini JC; Lewis MB; Chen K
    Am J Med Genet; 1993 Jan; 45(2):241-5. PubMed ID: 8456809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight mutations including 5 novel ones in the COL1A1 gene in Czech patients with osteogenesis imperfecta.
    Hruskova L; Fijalkowski I; Van Hul W; Marik I; Mortier G; Martasek P; Mazura I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):442-7. PubMed ID: 27132807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.
    Cabral WA; Milgrom S; Letocha AD; Moriarty E; Marini JC
    J Med Genet; 2006 Aug; 43(8):685-90. PubMed ID: 16882741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dental findings in osteogenesis imperfecta: I. Occurrence and expression of type I dentinogenesis imperfecta.
    Lukinmaa PL; Ranta H; Ranta K; Kaitila I
    J Craniofac Genet Dev Biol; 1987; 7(2):115-25. PubMed ID: 3624417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.